Background: During the lockdown period caused by the SARS‐CoV‐2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in pa‐ tients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology Service of Umberto I Hospital, aged between 6 and 16 years old, di‐ agnosed with asthma and/or rhinitis and sensitized to grass pollen or dust mite. We sent an email with 12 multiple‐choice questions investigating several areas: type of disease and sensitization, recurrence of symptoms, medication use during lockdown compared to the same period of the previous year. Results: The results of 82 questionnaires showed that 17.8% of patients suffered from asthma, 24.4% from rhinitis, and 57.8% from both. Within the group of asthmatic children, most of them presented an improvement of their symptoms. Likewise, with regard to allergic rhi‐ nitis, most of them reported better clinical conditions. Regarding treatment, we observed a global decrease in the use of on‐demand therapies (salbutamol, nasal corticosteroid, and antihistamine) for both pathologies. In addition, there was a reduction in the use of basal therapy for asthma and rhinitis from 2019 (23.3%) to 2020 (15.5%). Conclusions: Our data show a general trend of clinical improvement and a reduction in the use of on‐demand and basal therapy in allergic children during the lockdown.

Updates on Children with Allergic Rhinitis and Asthma during the COVID‐19 Outbreak / Brindisi, Giulia; De Vittori, Valentina; De Nola, Rosalba; Pignataro, Elia; Anania, Caterina; De Castro, Giovanna; Cinicola, Bianca; Gori, Alessandra; Cicinelli, Ettore; Zicari, Anna Maria. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 10:11(2021), pp. 1-6. [10.3390/jcm10112278]

Updates on Children with Allergic Rhinitis and Asthma during the COVID‐19 Outbreak

Giulia Brindisi
Writing – Original Draft Preparation
;
Valentina De Vittori
Writing – Review & Editing
;
Elia Pignataro;Caterina Anania
Software
;
Giovanna De Castro
Data Curation
;
Bianca Cinicola;Anna Maria Zicari
Validation
2021

Abstract

Background: During the lockdown period caused by the SARS‐CoV‐2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in pa‐ tients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology Service of Umberto I Hospital, aged between 6 and 16 years old, di‐ agnosed with asthma and/or rhinitis and sensitized to grass pollen or dust mite. We sent an email with 12 multiple‐choice questions investigating several areas: type of disease and sensitization, recurrence of symptoms, medication use during lockdown compared to the same period of the previous year. Results: The results of 82 questionnaires showed that 17.8% of patients suffered from asthma, 24.4% from rhinitis, and 57.8% from both. Within the group of asthmatic children, most of them presented an improvement of their symptoms. Likewise, with regard to allergic rhi‐ nitis, most of them reported better clinical conditions. Regarding treatment, we observed a global decrease in the use of on‐demand therapies (salbutamol, nasal corticosteroid, and antihistamine) for both pathologies. In addition, there was a reduction in the use of basal therapy for asthma and rhinitis from 2019 (23.3%) to 2020 (15.5%). Conclusions: Our data show a general trend of clinical improvement and a reduction in the use of on‐demand and basal therapy in allergic children during the lockdown.
File allegati a questo prodotto
File Dimensione Formato  
Brindisi_Updates on Children_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 346.16 kB
Formato Adobe PDF
346.16 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1551632
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact